Annual ReportFiscal Year Ended Mar. 31, 2016
A First Look at Olympus
Goals of Olympus
Corporate Value Improvement and Management Strategy
- Financial / Non-Financial Highlights
- New Medium-Term Management Plan (16CSP) / Message from the President
- Discussion between the CFO and Analysts
- Special Feature: Foundations for Further Medical Business Growth (Global Manufacturing Strategy / Initiatives for Accelerating Medical Business Growth in the U.S. / Potential for Advancement of Endoscopic Surgery and Expectations for Olympus)
- At a Glance
- Review of Business Segments (Medical Business / Scientific Solutions Business / Imaging Business)
Management Resources Supporting Competitive Edge
- R&D Activities / Intellectual Property Activities / Human Resources / Contribution to Society / Harmony with the Environment
- Conversation between an Outside Director (Chairman of the Board of Directors) and the President
- Corporate Governance / Compliance / Message from the Chief Compliance Officer
- Management Structure
Fact Data
- Financial Section (Analysis of Business Results, Financial Position, and Cash Flows / Risk Information / Consolidated Financial Statements and Notes / Independent Auditor's Report)
- Olympus Group Companies
- Corporate Information
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012